Renovaro Biosciences (RENB) Q2 2021 Earnings

24SepExpected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.36
-0.26
-0.15
-0.05

Details

Expected EPS
N/A
Actual EPS
-0.36
Surprise EPS
-0.36
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.36 per share for Q2 2021.

0 Comments

Share your thoughts